Results
| . | Treatment group sample size . | Control group sample size . | Treatment group median . | Control group median . | Treatment group mean rank . | Control group mean rank . | U . | z-score . | Sig. (p-value) . | . |
|---|---|---|---|---|---|---|---|---|---|---|
| Scenario 1 | 45 | 31 | 1 | 0 | 44.18 | 34.59 | 521.50 | −2.064 | 0.039 | 0.046 |
| Scenario 2 | 1 | 1 | 44.21 | 34.57 | 520.50 | −2.220 | 0.026 | 0.046 | ||
| Scenario 3 | 4 | 4 | 47.61 | 32.22 | 415.00 | −3.615 | 0.000 | 0.117 | ||
| Scenario 4 | 4 | 3 | 49.26 | 31.09 | 364.00 | −3.895 | 0.000 | 0.163 | ||
| Scenario 5 | 4 | 0 | 57.92 | 25.12 | 95.50 | −6.747 | 0.000 | 0.533 |
| . | Treatment group sample size . | Control group sample size . | Treatment group median . | Control group median . | Treatment group mean rank . | Control group mean rank . | U . | z-score . | Sig. (p-value) . | . |
|---|---|---|---|---|---|---|---|---|---|---|
| Scenario 1 | 45 | 31 | 1 | 0 | 44.18 | 34.59 | 521.50 | −2.064 | 0.039 | 0.046 |
| Scenario 2 | 1 | 1 | 44.21 | 34.57 | 520.50 | −2.220 | 0.026 | 0.046 | ||
| Scenario 3 | 4 | 4 | 47.61 | 32.22 | 415.00 | −3.615 | 0.000 | 0.117 | ||
| Scenario 4 | 4 | 3 | 49.26 | 31.09 | 364.00 | −3.895 | 0.000 | 0.163 | ||
| Scenario 5 | 4 | 0 | 57.92 | 25.12 | 95.50 | −6.747 | 0.000 | 0.533 |